Trial Profile
A multicentre phase II trial of gemcitabine and oxaliplatin (GEMOX) in patients with biliary tract cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Gemcitabine (Primary) ; Oxaliplatin (Primary)
- Indications Biliary cancer
- Focus Therapeutic Use
- Acronyms EXIBIT
- 01 Sep 2008 Results published in the British Journal of Cancer.
- 27 Jan 2007 Status changed from in progress to completed
- 18 Oct 2005 New trial record.